tiprankstipranks
Lunai Bioworks (LNAI)
NASDAQ:LNAI
US Market
LNAI
Lunai Bioworks
RESEARCH TOOLSreports

Lunai Bioworks (LNAI) Ratios

248 Followers

Lunai Bioworks Ratios

LNAI's free cash flow for Q3 2025 was $0.47. For the 2025 fiscal year, LNAI's free cash flow was decreased by $ and operating cash flow was $-68.15. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 21
Liquidity Ratios
Current Ratio
 0.19 0.04 0.07 0.23 1.48
Quick Ratio
 0.19 0.04 0.07 0.23 1.48
Cash Ratio
 0.16 <0.01 <0.01 0.17 1.42
Solvency Ratio
 -6.60 -6.01 -2.83 -3.35 -9.43
Operating Cash Flow Ratio
 -0.27 -0.27 -0.36 -1.07 -2.44
Short-Term Operating Cash Flow Coverage
 -4.11 -0.83 -4.48 -2.55 -13.11
Net Current Asset Value
$ -15.68M$ -28.53M$ -29.15M$ -9.23M$ -2.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.14 1.24 0.02 0.10 0.08
Debt-to-Equity Ratio
 -0.15 -0.48 0.03 0.12 0.10
Debt-to-Capital Ratio
 -0.17 -0.91 0.03 0.11 0.09
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.06
Financial Leverage Ratio
 -1.03 -0.39 1.24 1.25 1.17
Debt Service Coverage Ratio
 -5.17 -1.81 -17.58 -7.29 -71.80
Interest Coverage Ratio
 -16.23 -25.56 -33.53 -54.54 -311.33
Debt to Market Cap
 0.13 0.25 0.11 0.36 0.48
Interest Debt Per Share
 0.65 5.28 0.64 1.12 1.41
Net Debt to EBITDA
 0.18 -0.55 -0.04 -0.10 0.02
Profitability Margins
Gross Profit Margin
-360.71%0.00%0.00%0.00%0.00%
EBIT Margin
-46991.97%0.00%0.00%0.00%0.00%
EBITDA Margin
-46531.27%0.00%0.00%0.00%0.00%
Operating Profit Margin
-46991.97%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-612568.11%0.00%0.00%0.00%0.00%
Net Profit Margin
-612568.11%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-612568.11%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
1303.56%959.79%108.31%102.92%97.72%
Return on Assets (ROA)
-1300.98%-2162.69%-54.21%-68.07%-134.03%
Return on Equity (ROE)
892.52%833.76%-67.00%-85.34%-156.20%
Return on Capital Employed (ROCE)
104.45%88.63%-61.47%-81.55%-148.47%
Return on Invested Capital (ROIC)
120.87%165.94%-60.13%-74.01%-145.76%
Return on Tangible Assets
-3395.17%-8469.10%-2345.98%-989.60%-997.01%
Earnings Yield
-1816.83%-472.99%-397.73%-309.34%-947.14%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 0.01 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 1.62 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 >-0.01 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -47.95K -35.50K 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 47.95K 35.50K 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.68 -3.82 -1.13 -2.09 -3.00
Free Cash Flow Per Share
 -1.68 -3.82 -1.13 -2.10 -3.00
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -4.24K -2.62M -155.78 -395.46 -3.05K
Capital Expenditure Coverage Ratio
 -4.24K -2.62M -155.78 -395.46 -3.05K
Operating Cash Flow Coverage Ratio
 -3.73 -0.77 -2.90 -2.10 -2.24
Operating Cash Flow to Sales Ratio
 -251.09 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-51.33%-20.92%-49.67%-92.02%-131.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.05 -0.21 -0.25 -0.32 -0.11
Price-to-Sales (P/S) Ratio
 456.81 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 -0.69 -1.76 0.17 0.28 0.16
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.82 -4.78 -2.01 -1.09 -0.76
Price-to-Operating Cash Flow Ratio
 -1.25 -4.78 -2.03 -1.09 -0.76
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.01 >-0.01 <0.01 >-0.01
Price-to-Fair Value
 -0.69 -1.76 0.17 0.28 0.16
Enterprise Value Multiple
 -0.80 -2.59 -0.30 -0.43 -0.09
Enterprise Value
 8.50M 47.71M 25.80M 16.55M 9.82M
EV to EBITDA
 -0.87 -2.59 -0.30 -0.43 -0.09
EV to Sales
 406.01 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -1.62 -6.06 -2.34 -1.40 -0.62
EV to Operating Cash Flow
 -1.62 -6.06 -2.35 -1.41 -0.62
Tangible Book Value Per Share
 -5.00 -13.32 -2.81 -1.38 -0.12
Shareholders’ Equity Per Share
 -3.06 -10.35 13.53 8.26 13.82
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 >-0.01
Revenue Per Share
 <0.01 0.00 0.00 0.00 0.00
Net Income Per Share
 -41.06 -86.27 -9.07 -7.05 -21.59
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 13.04 9.60 1.03 1.02 1.00
Research & Development to Revenue
 7.95 0.00 0.00 0.00 0.00
SG&A to Revenue
 458.36 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 51.53 0.00 0.00 0.00 0.00
Income Quality
 0.04 0.04 0.12 0.30 0.14
Currency in USD